BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 32024945)

  • 1. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
    Nicoletti P; Dellinger A; Li YJ; Barnhart HX; Chalasani N; Fontana RJ; Odin JA; Serrano J; Stolz A; Etheridge AS; Innocenti F; Govaere O; Grove JI; Stephens C; Aithal GP; Andrade RJ; Bjornsson ES; Daly AK; Lucena MI; Watkins PB; ; ;
    Gastroenterology; 2023 Mar; 164(3):454-466. PubMed ID: 36496055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
    Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
    J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
    Chalasani N; Li YJ; Dellinger A; Navarro V; Bonkovsky H; Fontana RJ; Gu J; Barnhart H; Phillips E; Lammert C; Schwantes-An TH; Nicoletti P; Kleiner DE; Hoofnagle JH;
    J Hepatol; 2023 Feb; 78(2):293-300. PubMed ID: 36152763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations.
    Bonkovsky HL; Ghabril M; Nicoletti P; Dellinger A; Fontana RJ; Barnhart H; Gu J; Daly AK; Aithal GP; Phillips EJ; Kleiner DE;
    Liver Int; 2024 Jun; 44(6):1409-1421. PubMed ID: 38451034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
    Urban TJ; Shen Y; Stolz A; Chalasani N; Fontana RJ; Rochon J; Ge D; Shianna KV; Daly AK; Lucena MI; Nelson MR; Molokhia M; Aithal GP; Floratos A; Pe'er I; Serrano J; Bonkovsky H; Davern TJ; Lee WM; Navarro VJ; Talwalkar JA; Goldstein DB; Watkins PB; ; ; ; ;
    Pharmacogenet Genomics; 2012 Nov; 22(11):784-95. PubMed ID: 22968431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.
    Nicoletti P; Dellinger A; Li YJ; Barnhart H; Phillips E; Chalasani N;
    Am J Gastroenterol; 2024 Jan; 119(1):200-202. PubMed ID: 37552102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and Epigenetic Basis of Drug-Induced Liver Injury.
    Singh S; Kumar PVSNK; Kumar JP; Tomo S; Yadav D; Sharma P; Rao M; Banerjee M
    Semin Liver Dis; 2023 May; 43(2):163-175. PubMed ID: 37225145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding role of HLA gene tests for predicting drug side effects.
    Petry N; Forest K; Wilke RA
    Am J Med Sci; 2024 Jan; 367(1):14-20. PubMed ID: 37838157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature.
    Liao JM; Zhan Y; Zhang Z; Cui JJ; Yin JY
    Front Pharmacol; 2023; 14():1288068. PubMed ID: 38027017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy.
    Eis PS; Bruno CD; Richmond TA; Koralnik IJ; Hanson BA; Major EO; Chow CR; Hendel-Chavez H; Stankoff B; Gasnault J; Taoufik Y; Hatchwell E
    Front Neurol; 2020; 11():186. PubMed ID: 32256442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens.
    Nicoletti P; Devarbhavi H; Goel A; Venkatesan R; Eapen CE; Grove JI; Zafer S; Bjornsson E; Lucena MI; Andrade RJ; Pirmohamed M; Wadelius M; Larrey D; Maitland-van der Zee AH; Ibanez L; Watkins PB; Daly AK; Aithal GP
    Clin Pharmacol Ther; 2021 Apr; 109(4):1125-1135. PubMed ID: 33135175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method.
    Teschke R; Danan G
    Medicines (Basel); 2024 Apr; 11(4):. PubMed ID: 38667507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated liver injury following COVID-19 vaccination.
    Schinas G; Polyzou E; Dimakopoulou V; Tsoupra S; Gogos C; Akinosoglou K
    World J Virol; 2023 Mar; 12(2):100-108. PubMed ID: 37033146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.
    Moyer AM; Gandhi MJ
    Methods Mol Biol; 2022; 2547():21-45. PubMed ID: 36068459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Progress of Pharmacogenomics in Drug-Induced Liver Injury.
    Shao Q; Mao X; Zhou Z; Huai C; Li Z
    Front Pharmacol; 2021; 12():735260. PubMed ID: 34552491
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress in study on the association between HLA genetic variation and adverse drug reactions.
    Liu Y; Zeng X; Ouyang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):404-413. PubMed ID: 33967088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA associations with infliximab-induced liver injury.
    Bruno CD; Fremd B; Church RJ; Daly AK; Aithal GP; Björnsson ES; Larrey D; Watkins PB; Chow CR
    Pharmacogenomics J; 2020 Oct; 20(5):681-686. PubMed ID: 32024945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.
    Nicoletti P; Werk AN; Sawle A; Shen Y; Urban TJ; Coulthard SA; Bjornsson ES; Cascorbi I; Floratos A; Stammschulte T; Gundert-Remy U; Nelson MR; Aithal GP; Daly AK;
    Pharmacogenet Genomics; 2016 May; 26(5):218-24. PubMed ID: 26959717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
    Lucena MI; Molokhia M; Shen Y; Urban TJ; Aithal GP; Andrade RJ; Day CP; Ruiz-Cabello F; Donaldson PT; Stephens C; Pirmohamed M; Romero-Gomez M; Navarro JM; Fontana RJ; Miller M; Groome M; Bondon-Guitton E; Conforti A; Stricker BH; Carvajal A; Ibanez L; Yue QY; Eichelbaum M; Floratos A; Pe'er I; Daly MJ; Goldstein DB; Dillon JF; Nelson MR; Watkins PB; Daly AK; ; ; ; ;
    Gastroenterology; 2011 Jul; 141(1):338-47. PubMed ID: 21570397
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.